|
SENP7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.602000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.955000E-01 |
| Normal-vs-Stage2 |
7.691000E-01 |
| Normal-vs-Stage3 |
9.604100E-02 |
| Normal-vs-Stage4 |
1.644560E-01 |
| Stage1-vs-Stage2 |
7.107800E-01 |
| Stage1-vs-Stage3 |
8.182400E-02 |
| Stage1-vs-Stage4 |
1.892790E-01 |
| Stage2-vs-Stage3 |
1.553990E-01 |
| Stage2-vs-Stage4 |
2.348000E-01 |
| Stage3-vs-Stage4 |
8.240000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.661000E-01 |
| Normal-vs-AfricanAmerican |
9.272600E-01 |
| Normal-vs-Asian |
7.114600E-01 |
| Caucasian-vs-AfricanAmerican |
8.540800E-01 |
| Caucasian-vs-Asian |
7.609000E-01 |
| AfricanAmerican-vs-Asian |
7.198600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.361000E-01 |
| Normal-vs-Female |
7.198800E-01 |
| Male-vs-Female |
4.940200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.180600E-01 |
| Normal-vs-Extreme_Weight |
7.214600E-01 |
| Normal-vs-Obese |
9.740600E-01 |
| Normal-vs-Extreme_Obese |
6.476200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.547200E-01 |
| Normal_Weight-vs-Obese |
3.550800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.475400E-01 |
| Extreme_Weight-vs-Obese |
6.409800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.014800E-01 |
| Obese-vs-Extreme_Obese |
6.935200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.041000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.220600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.254600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.402200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.812400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.020400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.237400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.478000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.165240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.326800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.533950E-01 |
| Normal-VS-Type2 PRCC |
4.762900E-04 |
| Normal-VS-KIRP CIMP |
9.179300E-03 |
| Normal-VS-Unclassified PRCC |
5.926200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.99436039799639E-12 |
| Type1 PRCC-VS-KIRP CIMP |
1.179260E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.705800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.608200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.382200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.880260E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.102410E-01 |
| Normal-vs-N1 |
1.402210E-01 |
| Normal-vs-N2 |
5.099700E-02 |
| N0-vs-N1 |
9.295400E-01 |
| N0-vs-N2 |
2.019400E-01 |
| N1-vs-N2 |
1.837590E-01 |
|
|
